Florkowski C M, Walmsley T A, Brennan S O, George P M
Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand.
Postgrad Med J. 2003 Mar;79(929):174-5. doi: 10.1136/pmj.79.929.174.
A woman was screened for diabetes using glycated haemoglobin (HbA1c). Vastly different results were obtained by high performance liquid chromatography (45%), immunoassay (2.9%), and affinity chromatography (4.2%) compared with the non-diabetic range of less than 6.4%. Mass spectral studies confirmed the presence a haemoglobin variant, haemoglobin Marseille-Long Island which had confounded interpretation by all methods.
一名女性接受了糖化血红蛋白(HbA1c)检测以筛查糖尿病。与非糖尿病范围低于6.4%相比,采用高效液相色谱法(45%)、免疫分析法(2.9%)和亲和色谱法(4.2%)得出的结果差异很大。质谱研究证实存在一种血红蛋白变体,即马赛-长岛血红蛋白,它干扰了所有方法的解读。